About our PCR test
Molecular Vision Laboratory (MVL) is a CAP and CLIA-certified molecular diagnostic laboratory that provides state-of-the-art genetic testing for clients worldwide. We are a genetic testing reference laboratory for clinical trials of several inherited retinal dystrophies. We perform high complexity testing routinely and we are well-equipped with latest technologies including Next Generation Sequencing and quantitative PCR.
Results are for the identification of SARS-CoV-2 (COVID-19) RNA. The SARS-CoV-2 (COVID-19) RNA is generally detectable in upper respiratory and bronchoalveolar lavage (BAL) specimens during the acute phase of infection. Positive results are indicat ive of the presence of SARS-CoV-2 (COVID-19) RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities. Negative results do not preclude SARS-CoV-2 (COVID-19) infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.
DISCLAIMER: This test was developed, and its performance characteristics determined by Molecular Vision Lab. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. Sample collection step is the most critical step for the performance of the test. False negative result may occur due to sub-optimal collections of saliva samples. Additionally, various infection stages may produce different number of viruses in collections. A negative result only suggests no detectable viruses are present by the method and/or at the current stage of infection. Repeating testing at a different stage of infection may be necessary.
